6533b852fe1ef96bd12aabed
RESEARCH PRODUCT
Presepsin value predicts the risk of developing severe/critical COVID-19 illness: results of a pooled analysis
Fabian Sanchis-gomarBrandon Michael HenryGiuseppe Lippisubject
2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industryCritical IllnessSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Biochemistry (medical)Clinical BiochemistrycoronavirusLipopolysaccharide ReceptorsCOVID-19General Medicinemedicine.disease_causeVirologyPeptide FragmentsCOVID-19 biomarkers coronaviruspresepsinC-Reactive ProteinPooled analysispresepsinHumansMedicinebusinessValue (mathematics)BiomarkersCoronavirus| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-07-30 | Clinical Chemistry and Laboratory Medicine (CCLM) |